MX2021008522A - Proceso para la preparacion de comprimidos faciles de tomar que contienen extracto seco de hojas de ginkgo biloba. - Google Patents

Proceso para la preparacion de comprimidos faciles de tomar que contienen extracto seco de hojas de ginkgo biloba.

Info

Publication number
MX2021008522A
MX2021008522A MX2021008522A MX2021008522A MX2021008522A MX 2021008522 A MX2021008522 A MX 2021008522A MX 2021008522 A MX2021008522 A MX 2021008522A MX 2021008522 A MX2021008522 A MX 2021008522A MX 2021008522 A MX2021008522 A MX 2021008522A
Authority
MX
Mexico
Prior art keywords
dry extract
ginkgo biloba
tablets
leaves
present
Prior art date
Application number
MX2021008522A
Other languages
English (en)
Inventor
Joachim Herrmann
Andreas Rothe
Original Assignee
Dr Willmar Schwabe Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Willmar Schwabe Gmbh & Co Kg filed Critical Dr Willmar Schwabe Gmbh & Co Kg
Publication of MX2021008522A publication Critical patent/MX2021008522A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Nutrition Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a un proceso para la preparación de un comprimido de desintegración rápida con un tiempo de desintegración de 15 minutos como máximo para la administración peroral de un extracto seco de las hojas de Ginkgo biloba y con un peso total del comprimido entre 150 mg y 300 mg por cada 100 mg de extracto de ginkgo contenido. También es un objetivo de la invención proporcionar comprimidos de desintegración rápida que contengan extracto seco de las hojas de Ginkgo biloba, las cuales, debido a sus dimensiones más pequeñas, son más fáciles de tomar que los comprimidos utilizados hasta ahora. En una modalidad preferida, los comprimidos no contienen lactosa por lo tanto también son bien tolerados.
MX2021008522A 2019-01-15 2020-01-08 Proceso para la preparacion de comprimidos faciles de tomar que contienen extracto seco de hojas de ginkgo biloba. MX2021008522A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19151878.6A EP3682870B1 (de) 2019-01-15 2019-01-15 Verfahren zur herstellung von leicht einzunehmenden tabletten mit trockenextrakt aus ginkgo biloba blättern
PCT/EP2020/050306 WO2020148125A1 (de) 2019-01-15 2020-01-08 Verfahren zur herstellung von leicht einzunehmenden tabletten mit trockenextrakt aus ginkgo biloba blättern

Publications (1)

Publication Number Publication Date
MX2021008522A true MX2021008522A (es) 2021-11-12

Family

ID=65033398

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021008522A MX2021008522A (es) 2019-01-15 2020-01-08 Proceso para la preparacion de comprimidos faciles de tomar que contienen extracto seco de hojas de ginkgo biloba.

Country Status (22)

Country Link
US (1) US20220080006A1 (es)
EP (2) EP3682870B1 (es)
JP (1) JP7382409B2 (es)
KR (1) KR20210114974A (es)
CN (1) CN113365612B (es)
AU (1) AU2020208564A1 (es)
CA (1) CA3122196A1 (es)
CL (1) CL2021001668A1 (es)
CO (1) CO2021010578A2 (es)
EC (1) ECSP21059253A (es)
ES (1) ES2958082T3 (es)
HR (1) HRP20231170T1 (es)
HU (1) HUE063900T2 (es)
IL (1) IL284825A (es)
MA (1) MA53570B1 (es)
MX (1) MX2021008522A (es)
PL (1) PL3682870T3 (es)
PT (1) PT3682870T (es)
RS (1) RS64615B1 (es)
SG (1) SG11202107094XA (es)
TN (1) TN2021000116A1 (es)
WO (1) WO2020148125A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023246722A1 (en) * 2022-06-20 2023-12-28 Aptorum Therapeutics Limited Dioscorea polystachya tablet formulation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1623593A (zh) * 2003-12-05 2005-06-08 北京博尔达生物技术开发有限公司 银杏叶提取物固体速溶制剂及制备方法
CN1237981C (zh) * 2003-12-31 2006-01-25 北京科信必成医药科技发展有限公司 银杏叶口腔崩解片及其制备方法
CN1273116C (zh) * 2004-06-22 2006-09-06 张晴龙 一种银杏叶口腔崩解片及其制备方法
DE102005014272A1 (de) * 2005-03-24 2006-09-28 Rhein Chemie Rheinau Gmbh Mikrogele und Verdickungsmittel enthaltende Zusammensetzungen
CN1939355A (zh) 2005-09-30 2007-04-04 江西本草天工科技有限责任公司 银杏叶分散片
US20090208576A1 (en) * 2006-03-31 2009-08-20 Gandhi Anilkumar S Orally Disintegrating Tablets
WO2009038145A1 (ja) 2007-09-19 2009-03-26 Asahi Breweries, Ltd. 漢方エキス、生薬エキスあるいは天然物抽出エキスまたはそれらの混合物等の天然物由来物質を含有する顆粒物の製造方法およびその顆粒物から製造する錠剤の製造方法
HUE041715T2 (hu) 2007-12-21 2019-05-28 Dr Willmar Schwabe Gmbh & Co Kg Ginkgo biloba levél-kivonat alkalmazása
MX341428B (es) 2011-04-27 2016-08-18 Dr Willmar Schwabe Gmbh & Co Kg Tableta de liberacion controlada de extracto de ginkgo biloba y procedimiento para su obtencion.
CN103976967A (zh) * 2014-06-04 2014-08-13 湖南科技学院 一种银杏内酯舌下片及其制备方法
DE202014005450U1 (de) 2014-07-04 2015-10-06 Ursapharm Arzneimittel Gmbh Lactosefreies Arzneimittel

Also Published As

Publication number Publication date
CL2021001668A1 (es) 2021-12-31
US20220080006A1 (en) 2022-03-17
AU2020208564A1 (en) 2021-06-24
ECSP21059253A (es) 2021-09-30
WO2020148125A1 (de) 2020-07-23
ES2958082T3 (es) 2024-02-01
SG11202107094XA (en) 2021-07-29
PT3682870T (pt) 2023-09-25
CA3122196A1 (en) 2020-07-23
RS64615B1 (sr) 2023-10-31
HRP20231170T1 (hr) 2024-01-19
MA53570A1 (fr) 2022-06-30
CO2021010578A2 (es) 2021-08-30
CN113365612B (zh) 2023-11-17
JP2022518163A (ja) 2022-03-14
CN113365612A (zh) 2021-09-07
EP4248955A3 (de) 2023-11-22
PL3682870T3 (pl) 2023-12-11
IL284825A (en) 2021-08-31
EP3682870B1 (de) 2023-08-30
EP3682870A1 (de) 2020-07-22
EP4248955A2 (de) 2023-09-27
MA53570B1 (fr) 2023-01-31
TN2021000116A1 (en) 2023-01-05
HUE063900T2 (hu) 2024-02-28
KR20210114974A (ko) 2021-09-24
JP7382409B2 (ja) 2023-11-16

Similar Documents

Publication Publication Date Title
WO2009043844A3 (en) Orodispersible tablets
MXPA04012464A (es) Comprimidos bucodispersables y proceso para su obtencion.
WO2007002666A3 (en) Pharmaceutical and therapeutic compostions derived from garcinia mangostana l plant
WO2007020382A3 (en) Plant-based medicament for the treatment of liver disease
PH12017502325A1 (en) Orodispersible dosage unit containing an estetrol component
AP2004002998A0 (en) Intraorally disintegrating valdecoxib compositions
MX2021008522A (es) Proceso para la preparacion de comprimidos faciles de tomar que contienen extracto seco de hojas de ginkgo biloba.
NO20090980L (no) Kapecitabin pediatriske tabeletter
PH12017502249A1 (en) Tofacitinib orally disintegrating tablets
MA43876A (fr) Compositions pharmaceutiques et leur utilisations contre les maladies de surcharge lysosomale
UA92077C2 (uk) Таблетка, що диспергується у роті
Hajiaghaee et al. Herbal medicine in the treatment of Alzheimer’s disease
Villegas et al. Ginkgolides and Huperzine A for complementary treatment of Alzheimer's disease
WO2008039351A3 (en) Method of manufacturing tablets containing pharmacologically active agents
Tinari et al. Mitoptosis: different pathways for mitochondrial execution
WO2019004788A3 (ko) 브라우쏘칼콘 a를 유효성분으로 포함하는 염증성 장질환 예방 또는 치료용 약학 조성물
AU2013295227B2 (en) Compositions for treatment of cancer-related fatigue
KR101433193B1 (ko) 인지력의 개선과 치매의 치료 및 예방에 유효한 비타민 복합 조성물
WO2007050599A8 (en) Ginkgolides in the treatment and prevention of ovarian cancer
JP7235193B2 (ja) 固形組成物
WO2016175589A3 (ko) 혼합 생약 추출물을 함유하는 호흡기 질환 예방 또는 치료용 약학적 조성물
MX2023001014A (es) Composiciones farmaceuticas que comprenden venglustat.
MX2022004382A (es) Metodos para promover la produccion de scfa por microbiota intestinal.
Yiannakou et al. Efficacy and safety of prucalopride in men with chronic constipation: a phase 3 randomized, double blind, placebo controlled trial
Naveed et al. Manufacturing of new formulation of Pyridoxine HCL by direct compression method